Modified Nucleosides
(R)-N-(2,3-dihydro-1H-indenyl)adenosine
Quick view. We supply (R)-N-(2,3-dihydro-1H-indenyl)adenosine as a specialty product for nucleic acid chemistry and oligonucleotide research workflows. CAS 96392-15-3. Catalog target purity: Specification on request.
Product profile
(R)-N-(2,3-dihydro-1H-indenyl)adenosine is classified as nucleoside or protected nucleoside intermediate (Formula C19H21N5O4; molecular weight 383.4).
(R)-N-(2,3-dihydro-1H-indenyl)adenosine can serve as a starting material, protected intermediate or analytical comparator in nucleoside and nucleotide route development.
For (R)-N-(2,3-dihydro-1H-indenyl)adenosine, reported solubility: DMF: 10mg/mL; DMF:PBS (pH 7.2) (1:4): 0.2mg/mL; DMSO: 5mg/mL; Ethanol: 0.1mg/mL. Storage: Sealed in dry,2-8°C.
Names and search terms
Confirmed or normalized name variants
- PD 117519
- CI 947
- PD 11751
- PD 117519,R
- N-[(R)-Indan-1-yl]adenosine
- N-[(1R)-Indan-1-yl]adenosine
- N-[(1R)-2,3-Dihydro-1H-inden-1-yl]adenosine
- N-[[(R)-2,3-Dihydro-1H-inden]-1α-yl]adenosine
Useful catalog search terms
- CAS 96392-15-3
- Nucleoside or protected nucleoside intermediate
- Modified Nucleosides
Physicochemical data
| InChI | InChI=1S/C19H21N5O4/c25-7-13-15(26)16(27)19(28-13)24-9-22-14-17(20-8-21-18(14)24)23-12-6-5-10-3-1-2-4-11(10)12/h1-4,8-9,12-13,15-16,19,25-27H,5-7H2,(H,20,21,23)/t12-,13-,15-,16-,19-/m1/s |
|---|---|
| InChIKey | FSKMJUWPFLDDRS-BYMDKACISA-N |
| SMILES | OC[C@H]1O[C@@H](N2C3C(=C(N=CN=3)N[C@H]3C4=C(C=CC=C4)CC3)N=C2)[C@H](O)[C@@H]1O |
| Form | A solid |
| Color | White to off-white |
Release documentation
The current specification defines the analytical method and acceptance criteria; the released lot result is reported on the CoA.
Additional HPLC, MS or NMR documentation can be agreed during technical review where available.
Additional application examples
- Typical work includes protection/deprotection studies, phosphorylation or phosphitylation route scouting and impurity identification.
- The material can support medicinal-chemistry analog preparation and process-development feasibility studies.
Related products
(S)-cEt-rA
Modified Nucleosides · CAS: 1197033-34-3
BX-OP-0069S-Adenosylmethionine (SAM)
Modified Nucleosides · CAS: 485-80-3
BX-MN-0185(R-/S-) 5-Carbamoylhydroxy methyluridine
Modified Nucleosides · CAS: N/A
BX-MN-0186(R-/S-)5-(1-Hydroxy)(methoxycarbonyl)methyl uridine
Modified Nucleosides · CAS: N/A
BX-MN-0187(R-/S-)5-Carboxyhydroxymethyl uridine
Modified Nucleosides · CAS: N/A
BX-MN-01891-(2-Deoxy-b-D-xylofuranosyl)-5-methyluracil, 3'-beta-thymidine
Modified Nucleosides · CAS: N/A
Frequently asked questions
Can the package size for (R)-N-(2,3-dihydro-1H-indenyl)adenosine be customized?
Yes. Share the initial quantity, expected future scale, delivery timeline and packaging preference for review.
What information should be included in a quote request?
Quote catalog number BX-MN-0719 and CAS 96392-15-3, the intended research workflow, required quantity and any additional HPLC, MS or NMR documentation needed.
Product-family literature
The publications below provide peer-reviewed context for the Modified Nucleosides product family and its named chemistry.